Number of cellular immunotherapy pipeline globally by type 2020-2021
This statistic depicts the number of select types of cellular immunotherapies being developed globally in 2020 and 2021, including all phases from preclinical through approval and marketed products. Most of the therapies used chimeric antigen receptor T-cells (CAR-T).